BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30536577)

  • 1. Synthesis and Biological Evaluation of Substituted Indole and Its Analogs as Influenza A Virus Inhibitors.
    Zhang X; Zhang GN; Wang Y; Zhu M; Wang J; Li Z; Li D; Cen S; Wang Y
    Chem Biodivers; 2019 Feb; 16(2):e1800577. PubMed ID: 30536577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and anti-influenza A virus activity evaluation of novel indole containing derivatives of triazole.
    Ji K; Zhang GN; Zhao JY; Zhu M; Wang MH; Wang JX; Cen S; Wang YC; Li WY
    Bioorg Med Chem Lett; 2022 May; 64():128681. PubMed ID: 35304224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of inhibitors of influenza virus membrane fusion: synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series.
    Brancato V; Peduto A; Wharton S; Martin S; More V; Di Mola A; Massa A; Perfetto B; Donnarumma G; Schiraldi C; Tufano MA; de Rosa M; Filosa R; Hay A
    Antiviral Res; 2013 Aug; 99(2):125-35. PubMed ID: 23707194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of dihydropyrrolidones as novel inhibitors against influenza A virus.
    Liu T; Dai C; Sang H; Chen F; Huang Y; Liao H; Liu S; Zhu Q; Yang J
    Eur J Med Chem; 2020 Aug; 199():112334. PubMed ID: 32408213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boronic Acid Modifications Enhance the Anti-Influenza A Virus Activities of Novel Quindoline Derivatives.
    Wang W; Yin R; Zhang M; Yu R; Hao C; Zhang L; Jiang T
    J Med Chem; 2017 Apr; 60(7):2840-2852. PubMed ID: 28267329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, and Biological Evaluation of Itaconic Acid Derivatives as Potential Anti-Influenza Agents.
    Sethy B; Hsieh CF; Lin TJ; Hu PY; Chen YL; Lin CY; Tseng SN; Horng JT; Hsieh PW
    J Med Chem; 2019 Mar; 62(5):2390-2403. PubMed ID: 30753063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs.
    An L; Liu R; Tang W; Wu JG; Chen X
    Antiviral Res; 2014 Sep; 109():54-63. PubMed ID: 24971493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and in vitro anti-influenza A virus evaluation of novel quinazoline derivatives containing S-acetamide and NH-acetamide moieties at C-4.
    Zhang G; Wang M; Zhao J; Wang Y; Zhu M; Wang J; Cen S; Wang Y
    Eur J Med Chem; 2020 Nov; 206():112706. PubMed ID: 32805550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.
    Nacken W; Ehrhardt C; Ludwig S
    Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiviral activity of a series of novel quinoline derivatives as anti-RSV or anti-IAV agents.
    Wang M; Zhang G; Zhao J; Cheng N; Wang Y; Fu Y; Zheng Y; Wang J; Zhu M; Cen S; He J; Wang Y
    Eur J Med Chem; 2021 Mar; 214():113208. PubMed ID: 33571829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides as novel dual inhibitors of respiratory syncytial virus and influenza virus A.
    Zhang GN; Li Q; Zhao J; Zhang X; Xu Z; Wang Y; Fu Y; Shan Q; Zheng Y; Wang J; Zhu M; Li Z; Cen S; He J; Wang Y
    Eur J Med Chem; 2020 Jan; 186():111861. PubMed ID: 31734025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 5-Methoxy-2-(Diformylmethylidene)-3,3-Dimethylindole as an Anti-Influenza A Virus Agent.
    Tan MC; Wong WY; Ng WL; Yeo KS; Mohidin TB; Lim YY; Lafta F; Mohd Ali H; Ea CK
    PLoS One; 2017; 12(1):e0170352. PubMed ID: 28114392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in vitro genetic barrier of drug resistance.
    Ma C; Li F; Musharrafieh RG; Wang J
    Antiviral Res; 2016 Sep; 133():62-72. PubMed ID: 27478032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery of indole derivatives as novel hepatitis C virus inhibitors.
    Han Z; Liang X; Wang Y; Qing J; Cao L; Shang L; Yin Z
    Eur J Med Chem; 2016 Jun; 116():147-155. PubMed ID: 27061978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
    Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
    Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and antiviral activity of certain 3-substituted 2,5,6-trichloroindole nucleosides.
    Williams JD; Chen JJ; Drach JC; Townsend LB
    J Med Chem; 2004 Nov; 47(23):5753-65. PubMed ID: 15509174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based discovery of anti-influenza virus A compounds among medicines.
    Fukuoka M; Minakuchi M; Kawaguchi A; Nagata K; Kamatari YO; Kuwata K
    Biochim Biophys Acta; 2012 Feb; 1820(2):90-5. PubMed ID: 22108550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of the 2-phenyl-4,5,6,7-Tetrahydro-1H-indole as a novel anti-hepatitis C virus targeting scaffold.
    Andreev IA; Manvar D; Barreca ML; Belov DS; Basu A; Sweeney NL; Ratmanova NK; Lukyanenko ER; Manfroni G; Cecchetti V; Frick DN; Altieri A; Kaushik-Basu N; Kurkin AV
    Eur J Med Chem; 2015; 96():250-8. PubMed ID: 25890075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.
    Clark MP; Ledeboer MW; Davies I; Byrn RA; Jones SM; Perola E; Tsai A; Jacobs M; Nti-Addae K; Bandarage UK; Boyd MJ; Bethiel RS; Court JJ; Deng H; Duffy JP; Dorsch WA; Farmer LJ; Gao H; Gu W; Jackson K; Jacobs DH; Kennedy JM; Ledford B; Liang J; Maltais F; Murcko M; Wang T; Wannamaker MW; Bennett HB; Leeman JR; McNeil C; Taylor WP; Memmott C; Jiang M; Rijnbrand R; Bral C; Germann U; Nezami A; Zhang Y; Salituro FG; Bennani YL; Charifson PS
    J Med Chem; 2014 Aug; 57(15):6668-78. PubMed ID: 25019388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.